Amicus briefs fly in as IRA ‘fair price’ deadline looms

Am­i­cus briefs are pil­ing up in sup­port of drug price ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act ahead of a key Feb­ru­ary dead­line by which the gov­ern­ment is ex­pect­ed to pro­pose fair prices for se­lect­ed drugs.

AARP, ad­vo­ca­cy groups like Pub­lic Cit­i­zen and Doc­tors for Amer­i­ca, and re­searchers em­ployed by lead­ing uni­ver­si­ties have filed “friend of the court” briefs in sup­port of drug price ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act. Many of the ar­gu­ments re­sem­ble points made in pri­or briefs de­fend­ing the IRA, in­clud­ing ones filed in Sep­tem­ber in Mer­ck’s case.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.